Humanwell Healthcare (Group) Co Ltd. Stock Analysis 600079.SS

Humanwell Healthcare (Group) Co., Ltd. engages in the research and development, production, and sale of medical products. The company is headquartered in Wuhan, Hubei and currently employs 17,153 full-time employees. The Company’s main businesses include pharmaceutical manufacturing and pharmaceutical distribution. The pharmaceutical manufacturing segment produces injections, tablets, capsules, granules, pills, syrups, and ointments, primarily focusing on the central nervous system, steroid hormones, sexual health, and Uyghur medicine. The pharmaceutical distribution segment mainly focuses on drug sales and provides equipment, consumables, diagnostic reagents, and medical logistics services. The firm also has an international business segment, operating in the United States, Europe, and Africa.